Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How We Collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Identification of C4BPA as a genetically informed drug target in NSCLC: an integrative single-cell and multi-omics study based on the druggable genes

Submitted by Anna Hakala on Mon, 11/17/2025 - 15:43
  • Read more about Identification of C4BPA as a genetically informed drug target in NSCLC: an integrative single-cell and multi-omics study based on the druggable genes

Meta-analysis of exome-wide gene burden analysis of breast cancer susceptibility genes

Submitted by Anna Hakala on Mon, 11/17/2025 - 15:42
  • Read more about Meta-analysis of exome-wide gene burden analysis of breast cancer susceptibility genes

Trans-eQTL mapping prioritises USP18 as a negative regulator of interferon response at a lupus risk locus

Submitted by Anna Hakala on Mon, 11/17/2025 - 15:41
  • Read more about Trans-eQTL mapping prioritises USP18 as a negative regulator of interferon response at a lupus risk locus

Genetic underpinnings of the heterogeneous impact of obesity on lipid levels and cardiovascular disease

Submitted by Anna Hakala on Mon, 11/17/2025 - 15:38
  • Read more about Genetic underpinnings of the heterogeneous impact of obesity on lipid levels and cardiovascular disease

Genetic evidence informs the direction of therapeutic modulation in drug development

Submitted by Anna Hakala on Mon, 11/17/2025 - 15:36
  • Read more about Genetic evidence informs the direction of therapeutic modulation in drug development

Genetic analyses across cardiovascular traits: leveraging genetic correlations to empower locus discovery and prediction in common cardiovascular diseases

Submitted by Anna Hakala on Mon, 11/17/2025 - 15:35
  • Read more about Genetic analyses across cardiovascular traits: leveraging genetic correlations to empower locus discovery and prediction in common cardiovascular diseases

Dissecting immune cell-specific genetics in migraine: a multi-omics framework for target discovery and therapeutic prioritization

Submitted by Anna Hakala on Mon, 11/17/2025 - 15:35
  • Read more about Dissecting immune cell-specific genetics in migraine: a multi-omics framework for target discovery and therapeutic prioritization

Brain–heart–eye axis revealed by multi-organ imaging genetics and proteomics

Submitted by Anna Hakala on Mon, 11/17/2025 - 14:58
  • Read more about Brain–heart–eye axis revealed by multi-organ imaging genetics and proteomics

Plasma caffeine level as a protective factor against age-related eye diseases: a two-sample Mendelian randomization study

Submitted by Anna Hakala on Mon, 11/17/2025 - 11:30
  • Read more about Plasma caffeine level as a protective factor against age-related eye diseases: a two-sample Mendelian randomization study

Causal Relationship Between Plasma Protein-to-Protein Ratios and Rheumatoid Arthritis: A Proteome-wide Mendelian Randomization Study

Submitted by Anna Hakala on Mon, 11/17/2025 - 11:29
  • Read more about Causal Relationship Between Plasma Protein-to-Protein Ratios and Rheumatoid Arthritis: A Proteome-wide Mendelian Randomization Study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement